Researchers in Brazil Struggle to Get Solid COVID-19 Death Counts

After combing through data on public death notices in Minas Gerais state, scientists say the coronavirus death toll in the country is worse than reported.

Written byChris Baraniuk
| 4 min read
belo horizonte minas gerais brazil covid-19 coronavirus pandemic death count data lag sinan sars

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Belo Horizonte, Minas Gerais, Brazil
© ISTOCK.COM, BRASILNUT1

Brazil is a major new epicenter of COVID-19—but the official figures don’t tell the whole story. That’s what researchers have concluded after combing through public death notice data from the second most-populous state in the country and comparing it to officially reported figures.

A team of scientists examined data gleaned from public notary death notices—legal documents required for arranging a burial—in Minas Gerais state and published their results in a preprint on medRxiv May 23. They found that notaries recorded 201 COVID-19 deaths in March and April, versus 65 COVID-19 deaths reported in official statistics via a government system called The Notifiable Diseases Information System (SINAN). There is generally a lag between these data sources, but the team also found that notaries had recorded an unexpected surge of deaths due to other respiratory illnesses. The authors write that they suspect hundreds of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • chris baraniuk

    Chris Baraniuk is a freelance science journalist based in Northern Ireland who contributes to The Scientist. He has covered biological and medical science for a range of publications, including the BBC, the BMJ, and Mosaic. He also writes about nature, climate change, and technology. His background in the humanities has long proved invaluable in his quest to bring science stories to people from all walks of life.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies